Fundraising Fox株式会社カイオム・バイオサイエンス
2 known investors
Find your way into 株式会社カイオム・バイオサイエンス
Sign up to see every warm intro you have to 株式会社カイオム・バイオサイエンス
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社カイオム・バイオサイエンス team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs. It works to create drug candidates and build product pipelines through collaboration with external institutions.
Investors · 2
Frequently asked questions
- What does 株式会社カイオム・バイオサイエンス do?
- Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs. It works to create drug candidates and build product pipelines through collaboration with external institutions.
- Who are 株式会社カイオム・バイオサイエンス's investors?
- 株式会社カイオム・バイオサイエンス's investors include Fast Track Initiative, SMBC Venture Capital.